相似文献
1
Does FGF23 toxicity influence the outcome of chronic kidney disease?
Nephrol Dial Transplant. 2009 Jan;24(1):4-7. doi: 10.1093/ndt/gfn620. Epub 2008 Nov 7.
2
Does Fgf23-klotho activity influence vascular and soft tissue calcification through regulating mineral ion metabolism?
Kidney Int. 2008 Sep;74(5):566-70. doi: 10.1038/ki.2008.218. Epub 2008 Jun 4.
3
Regulation of fibroblast growth factor-23 signaling by klotho.
J Biol Chem. 2006 Mar 10;281(10):6120-3. doi: 10.1074/jbc.C500457200. Epub 2006 Jan 25.
4
Klotho: an elixir of youth for the vasculature?
J Am Soc Nephrol. 2011 Jan;22(1):5-7. doi: 10.1681/ASN.2010111190. Epub 2010 Dec 16.
5
In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis.
FASEB J. 2009 Feb;23(2):433-41. doi: 10.1096/fj.08-114397. Epub 2008 Oct 3.
6
Osteo-renal cross-talk and phosphate metabolism by the FGF23-Klotho system.
Contrib Nephrol. 2013;180:1-13. doi: 10.1159/000346774. Epub 2013 May 3.
7
αKlotho and Chronic Kidney Disease.
Vitam Horm. 2016;101:257-310. doi: 10.1016/bs.vh.2016.02.007. Epub 2016 Mar 24.
8
The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis.
J Endocrinol. 2007 Jul;194(1):1-10. doi: 10.1677/JOE-07-0095.
9
Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model.
FASEB J. 2009 Nov;23(11):3702-11. doi: 10.1096/fj.08-123992. Epub 2009 Jul 7.
10
In vivo evidence for an interplay of FGF23/Klotho/PTH axis on the phosphate handling in renal proximal tubules.
Am J Physiol Renal Physiol. 2018 Nov 1;315(5):F1261-F1270. doi: 10.1152/ajprenal.00650.2017. Epub 2018 Jul 11.
引用本文的文献
1
Specialty grand challenge: existing issues and emerging frontiers in renal endocrinology.
Front Endocrinol (Lausanne). 2025 Jul 17;16:1651141. doi: 10.3389/fendo.2025.1651141. eCollection 2025.
2
Fibroblast growth factor 23 level modulates the hepatocyte's alpha-2-HS-glycoprotein transcription through the inflammatory pathway TNFα/NFκB.
Front Med (Lausanne). 2022 Dec 7;9:1038638. doi: 10.3389/fmed.2022.1038638. eCollection 2022.
3
The Role of Vitamin D in SARS-CoV-2 Infection and Acute Kidney Injury.
Int J Mol Sci. 2022 Jul 1;23(13):7368. doi: 10.3390/ijms23137368.
4
Vitamin D and Phosphate Interactions in Health and Disease.
Adv Exp Med Biol. 2022;1362:37-46. doi: 10.1007/978-3-030-91623-7_5.
5
Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets.
Toxins (Basel). 2021 Feb 13;13(2):142. doi: 10.3390/toxins13020142.
6
Endocrine regulation of MFS2 by branchless controls phosphate excretion and stone formation in Drosophila renal tubules.
Sci Rep. 2019 Jun 19;9(1):8798. doi: 10.1038/s41598-019-45269-x.
7
Thymic Epithelial Cell Support of Thymopoiesis Does Not Require .
J Immunol. 2018 Dec 1;201(11):3320-3328. doi: 10.4049/jimmunol.1800670. Epub 2018 Oct 29.
8
Dietary phosphate toxicity: an emerging global health concern.
Histochem Cell Biol. 2018 Dec;150(6):711-719. doi: 10.1007/s00418-018-1711-8. Epub 2018 Aug 25.
9
Fibroblast growth factor 23, iron and inflammation - are they related in early stages of chronic kidney disease?
Arch Med Sci. 2017 Jun;13(4):845-850. doi: 10.5114/aoms.2016.58647. Epub 2016 Mar 17.
10
αKlotho and Chronic Kidney Disease.
Vitam Horm. 2016;101:257-310. doi: 10.1016/bs.vh.2016.02.007. Epub 2016 Mar 24.
本文引用的文献
1
In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis.
FASEB J. 2009 Feb;23(2):433-41. doi: 10.1096/fj.08-114397. Epub 2008 Oct 3.
2
Amelioration of the premature ageing-like features of Fgf-23 knockout mice by genetically restoring the systemic actions of FGF-23.
J Pathol. 2008 Nov;216(3):345-55. doi: 10.1002/path.2409.
3
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.
N Engl J Med. 2008 Aug 7;359(6):584-92. doi: 10.1056/NEJMoa0706130.
4
Does Fgf23-klotho activity influence vascular and soft tissue calcification through regulating mineral ion metabolism?
Kidney Int. 2008 Sep;74(5):566-70. doi: 10.1038/ki.2008.218. Epub 2008 Jun 4.
5
Dynamics of parathyroid hormone secretion in health and secondary hyperparathyroidism.
Clin J Am Soc Nephrol. 2007 Nov;2(6):1283-305. doi: 10.2215/CJN.01520407. Epub 2007 Oct 17.
6
Can fibroblast growth factor 23 fine-tune therapies for diseases of abnormal mineral ion metabolism?
Nat Clin Pract Endocrinol Metab. 2007 Dec;3(12):788-9. doi: 10.1038/ncpendmet0667. Epub 2007 Oct 9.
7
A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis.
J Clin Invest. 2007 Sep;117(9):2684-91. doi: 10.1172/JCI31330.
8
Association of disorders in mineral metabolism with progression of chronic kidney disease.
Clin J Am Soc Nephrol. 2006 Jul;1(4):825-31. doi: 10.2215/CJN.02101205. Epub 2006 May 17.
9
New aspect of renal phosphate reabsorption: the type IIc sodium-dependent phosphate transporter.
Am J Nephrol. 2007;27(5):503-15. doi: 10.1159/000107069. Epub 2007 Aug 7.
10
Does renal ageing affect survival?
Ageing Res Rev. 2007 Oct;6(3):211-22. doi: 10.1016/j.arr.2007.06.001. Epub 2007 Jun 29.
Zotero 插件